Stock PIHLIS PIHLAJALINNA OYJ
Add to a list
To use this feature you must be a member
Log inSign up

Financials Pihlajalinna Oyj

Equities

PIHLIS

FI4000092556

Healthcare Facilities & Services

Real-time Estimate Cboe Europe
Other stock markets
 04:03:41 2024-04-30 am EDT 		5-day change 1st Jan Change
8.05 EUR +1.13% Intraday chart for Pihlajalinna Oyj +4.96% +13.88%
Apr. 16 Pihlajalinna plc announces Changes in Management Team CI
Apr. 10 Pihlajalinna plc Approves Dividend for the Year 2023, Payable on April 19, 2024 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 345.6 212.2 285.6 192.1 159.3 179.4 - -
Enterprise Value (EV) 1 538.3 407 480.3 577.8 512 543.2 532.9 546.4
P/E ratio 102 x 24.1 x 14.2 x 20.3 x 37.2 x 11.4 x 8.74 x 8.5 x
Yield - 2.13% 2.37% - 0.99% 2.98% 3.77% 4.61%
Capitalization / Revenue 0.67 x 0.42 x 0.49 x 0.28 x 0.22 x 0.25 x 0.24 x 0.27 x
EV / Revenue 1.04 x 0.8 x 0.83 x 0.84 x 0.71 x 0.75 x 0.72 x 0.82 x
EV / EBITDA 9.77 x 7.45 x 7.36 x 9 x 6.35 x 6.36 x 5.83 x 6.04 x
EV / FCF 25.2 x 10.9 x 11.4 x 16.1 x 9.13 x 13.3 x 11.4 x 13.8 x
FCF Yield 3.98% 9.17% 8.77% 6.21% 11% 7.5% 8.79% 7.23%
Price to Book 3.42 x 1.93 x 2.4 x 1.55 x 1.08 x 1.18 x 1.07 x 1.05 x
Nbr of stocks (in thousands) 22,620 22,618 22,594 22,550 22,562 22,532 - -
Reference price 2 15.28 9.380 12.64 8.520 7.060 7.960 7.960 7.960
Announcement Date 2/14/20 2/19/21 2/18/22 2/17/23 2/14/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 518.6 508.7 577.8 690.5 720 728.1 739.3 665.5
EBITDA 1 55.1 54.6 65.3 64.2 80.6 85.35 91.41 90.4
EBIT 1 20.8 20.8 30.3 18.6 29.1 35.15 39.3 36.85
Operating Margin 4.01% 4.09% 5.24% 2.69% 4.04% 4.83% 5.32% 5.54%
Earnings before Tax (EBT) 1 6.3 13.8 24.2 1.5 8.2 23.03 28.73 27.5
Net income 1 3.4 8.7 20.1 9.5 5.7 16.34 21.08 21.14
Net margin 0.66% 1.71% 3.48% 1.38% 0.79% 2.24% 2.85% 3.18%
EPS 2 0.1500 0.3900 0.8900 0.4200 0.1900 0.7009 0.9108 0.9364
Free Cash Flow 1 21.4 37.3 42.1 35.9 56.1 40.77 46.83 39.5
FCF margin 4.13% 7.33% 7.29% 5.2% 7.79% 5.6% 6.33% 5.94%
FCF Conversion (EBITDA) 38.84% 68.32% 64.47% 55.92% 69.6% 47.76% 51.23% 43.69%
FCF Conversion (Net income) 629.41% 428.74% 209.45% 377.89% 984.21% 249.56% 222.16% 186.83%
Dividend per Share 2 - 0.2000 0.3000 - 0.0700 0.2375 0.3000 0.3667
Announcement Date 2/14/20 2/19/21 2/18/22 2/17/23 2/14/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 140.6 154.7 163.1 173.7 165.2 188.4 187.8 183.6 165.6 183 188.7 184 167.9 185.9
EBITDA 1 18.8 14.9 16.5 16.9 18.9 12 21.4 18 20.5 20.7 22.1 21.1 21.55 21.4
EBIT 1 10 6 5.9 5.2 7.3 0.1 8.9 5.1 7.4 7.7 9.35 8.35 8.8 8.65
Operating Margin 7.11% 3.88% 3.62% 2.99% 4.42% 0.05% 4.74% 2.78% 4.47% 4.21% 4.95% 4.54% 5.24% 4.65%
Earnings before Tax (EBT) 1 8.5 4.6 -2.7 2.5 4.5 -2.8 7.5 2.4 4.4 -6.1 6.567 5.3 5.9 5.8
Net income 1 6.9 4.3 5.3 1.7 3.3 -0.7 5.5 2 3.5 -5.2 4.6 4 4.1 2.9
Net margin 4.91% 2.78% 3.25% 0.98% 2% -0.37% 2.93% 1.09% 2.11% -2.84% 2.44% 2.17% 2.44% 1.56%
EPS 2 0.3100 0.1900 0.2300 0.0800 0.1400 -0.0300 0.2400 0.0700 0.1300 -0.2500 0.2050 0.1750 0.1800 0.1300
Dividend per Share - - - - - - - - - - - - - -
Announcement Date 11/4/21 2/18/22 5/5/22 8/12/22 11/4/22 2/17/23 4/28/23 8/11/23 11/3/23 2/14/24 - - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 193 195 195 386 353 364 354 367
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 3.497 x 3.568 x 2.982 x 6.008 x 4.376 x 4.263 x 3.868 x 4.06 x
Free Cash Flow 1 21.4 37.3 42.1 35.9 56.1 40.8 46.8 39.5
ROE (net income / shareholders' equity) 3.03% 8.1% 16.1% 6.2% 3.4% 11% 13.1% 12.7%
ROA (Net income/ Total Assets) - - 4.48% 1.7% 0.86% 2.53% 3.21% 3.62%
Assets 1 - - 449.2 559.3 659.5 645.2 657.8 584.2
Book Value Per Share 2 4.470 4.850 5.270 5.500 6.560 6.730 7.410 7.590
Cash Flow per Share 2 1.630 2.030 2.520 2.880 3.500 3.210 3.570 3.000
Capex 1 15.4 9.9 14.8 29 22.9 36.4 36.7 30.7
Capex / Sales 2.97% 1.95% 2.56% 4.2% 3.18% 5% 4.97% 4.61%
Announcement Date 2/14/20 2/19/21 2/18/22 2/17/23 2/14/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Pihlajalinna Oyj

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
7.96 EUR
Average target price
8.3 EUR
Spread / Average Target
+4.27%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
PIHLAJALINNA OYJ Stock Pihlajalinna Oyj
+13.88% 192M
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.58% 85.02B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+15.05% 82.37B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+10.49% 29.29B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-10.17% 17.21B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-0.86% 16.7B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.40% 11.8B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+2.13% 12.15B
DAVITA INC. Stock DaVita Inc.
+31.86% 12.12B
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
-1.63% 12.13B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. PIHLIS Stock
  4. Financials Pihlajalinna Oyj